FurGPT Taps into Kadena’s Scalable PoW Network to Expand Emotional-AI Reach and Global Token Utility
Railtown AI Technologies Announces Intention to Complete the Amalgamation with AI Partnerships Corp.
Palma Ristorante Named Best Restaurant for Holiday Parties in Los Angeles 2025
Rinehardt Injury Attorneys’ John K. Rinehardt Honored Among Ohio’s Top 100 Super Lawyers for 2026
Flomary Group Unveils Upcoming Sustainable Collections
Tegoprubart was well-tolerated, with no drug-related serious adverse events Dose dependent target engagement was demonstrated,…
With Shipa Insights, DevOps and platform teams can instantly verify security compliance and identify policy…
TOKYO, May 31, 2022 – (JCN Newswire) – Yokogawa Electric Corporation and Mitsubishi Heavy Industries,…
TOKYO, May 31, 2022 – (JCN Newswire) – Hitachi High-Tech Corporation today announced the opening…
Panama City, Panama, May 31, 2022 – (ACN Newswire) – MetaMate is a pioneering project…
HONG KONG, May 31, 2022 – (ACN Newswire) – Macau leading gaming equipment supplier Asia…
BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading…
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
David D. Petratis to Retire Following Distinguished 40-Year Career, John H. Stone to Succeed Petratis…
NEW YORK & LONDON–(BUSINESS WIRE)–Genius Sports Limited (“Genius Sports”) (NYSE:GENI), the official data, technology and…
The HPC solution has been successfully applied at a top German auto manufacturer, achieving both…
SANDSIV’s highly secure, hyper-modern, on-premises VoC solution has enhanced Swisscom’s position as a leader in…
GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
AARHUS, Denmark, May 31, 2022 (GLOBE NEWSWIRE) — STipe Therapeutics (STipe), a company with a…
MONT-SAINT-GUIBERT, Belgium, May 31, 2022 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD)…
Multidisciplinary Steering Committee established to drive action includes patient advocacy leaders, healthcare professionals, biosimilar experts…
REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 31 May 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and…
Approval based on interim RAINBOWFISH data which show pre-symptomatic babies treated with Evrysdi for at…
Positive scientific opinion under Early Access to Medicines Scheme (EAMS) will make…
FDA accepts Dupixent® (dupilumab) for priority review in adults with prurigo nodularis Dupixent would be…